Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to announce its participation in the American College of Foot ...
Zacks.com on MSN5mon
Paragon 28's Shares Rise After Launch of Phantom Fibula Nail SystemThe Phantom Fibula Nail System expands Paragon 28’s innovative foot and ankle fracture portfolio, which includes various ...
ENGLEWOOD, Colo., March 07, 2025--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to ...
Hosted on MSN1mon
Zimmer Biomet's rating and oultook affirmed at Moody's as Paragon 28 deal enhances growth and diversifies businessParagon 28 boasts a wide range of surgical offerings and product systems that cover all major foot and ankle segments, including fracture and trauma, deformity correction, and joint replacement.
"We are thrilled to engage with foot and ankle specialists at ACFAS and showcase our latest innovations after an incredibly strong product launch cadence in 2024," said Albert DaCosta, CEO of Paragon ...
Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to announce its participation in the American Academy of ...
ENGLEWOOD, Colo., March 24, 2025--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback